Brixadi is an injectable buprenorphine treatment for opioid use disorders, its given weekly or monthly to reduce withdrawal symptoms and cravings.
Brixadi (buprenorphine) is an extended-release injection, FDA approved for the treatment of moderate to severe opioid use disorder (OUD).
